Zobrazeno 1 - 10
of 267
pro vyhledávání: '"I A, Karpov"'
Publikováno v:
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 33, Iss 5, Pp 7-19 (2023)
Aim: to present modern approaches to the differential diagnosis and treatment of anterior abdominal wall pain.Key points. Pain in the anterior abdominal wall is a common reason for visiting a gastroenterologist and is often misinterpreted. Signs that
Externí odkaz:
https://doaj.org/article/f859400108f44ec9baa6747ca27c1a8b
Publikováno v:
Travmatologiâ i Ortopediâ Rossii, Vol 27, Iss 2, Pp 114-123 (2021)
Background. The rarity of the disease and, in this regard, the lack of doctors awareness about the pathology, late diagnosis and severe complications of the musculoskeletal system emphasize the relevance of clinical case demonstrating. The uniqueness
Externí odkaz:
https://doaj.org/article/3dae5cc2a2c146bf914ee39969432462
Autor:
S. P. Lukashyk, O. V. Aleinikova, V. M. Tsyrkunov, I. A. Karpov, Y. I. Isaykina, O. V. Krasko
Publikováno v:
Архивъ внутренней медицины, Vol 11, Iss 2, Pp 132-145 (2021)
Introduction. Liver cirrhosis (LC) is the final stage in the progression of chronic diffuse diseases. As common, late stages of LC do not respond to conservative treatment methods, so liver transplantation is the most effective method at this stage.
Externí odkaz:
https://doaj.org/article/8b7ce5cfc2e04fd6bc507895287572b2
Autor:
Yu. A. Belkova, S. A. Rachina, R. S. Kozlov, V. M. Mishchenko, R. A. Pavlyukov, A. I. Abubakirova, B. V. Berezhanskiy, E. V. Eliseeva, N. A. Zubareva, I. A. Karpov, I. A. Kopylova, Sh. Kh. Palyutin, U. S. Portnyagina, O. V. Pribytkova, E. K. Samuylo
Publikováno v:
Антибиотики и Химиотерапия, Vol 61, Iss 1-2, Pp 15-31 (2020)
The results of the systemic antimicrobials (AM) consumption and expenditures assessment in the departments of surgery of multiprofile hospitals in different regions of the Russian Federation and the Republic of Belarus in 2009-2010 based on retrospec
Externí odkaz:
https://doaj.org/article/93614f32bc364f65aebb8afe05ae9ca4
Autor:
I. A. Karpov, N. V. Solovey
Publikováno v:
Антибиотики и Химиотерапия, Vol 63, Iss 9-10, Pp 19-25 (2020)
The article presents current data on antibiotic resistance and etiology of acute upper respiratory tract infections (tonsillopharyngitis, rhinosinusitis, otitis media); it discusses the possibilities of clinical differentiation between the bacterial
Externí odkaz:
https://doaj.org/article/c88f66766629434397c5ccbb6c3279c5
Autor:
E. L. Gasich, E. N. Krotkova, A. D. Kasko, K. Yu. Bulda, A. G. Krasko, E. A. Dorofeeva, I. A. Karpov
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 0, Iss 0 (2022)
INTRODUCTION. The high prevalence of mutations in the SARS-CoV-2 genome raises particular concerns about the resistance of the virus to current antiviral therapy, including inhibitors of the main protease, or 3C-like protease (3CLpro), and RNA-depend
Externí odkaz:
https://doaj.org/article/7d817525d0fa4c93a97dc1fd20a08ac5
Publikováno v:
Russian Chemical Bulletin. 72:1279-1282
Publikováno v:
Physics of Metals and Metallography. 123:924-932
Autor:
V. A. Shamanin, I. V. Karpov, P. А. Gervas, N. V. Cherdyntseva, E. I. Simolina, V. V. Kozlov, S. P. Kovalenko
Publikováno v:
Сибирский онкологический журнал, Vol 17, Iss 5, Pp 52-59 (2018)
Activating mutations of EGFR are associated with sensitivity of non-small cell lung cancer (NSCLC ) to tyrosine kinase inhibitors (TKI). Liquid biopsy using circulating cell-free tumor DNA (cfDNA) is proposed in cases when formalin fixed paraffin emb
Externí odkaz:
https://doaj.org/article/94c29e7e4b5a4b60917e541cd444965c
Autor:
S. V. Zhavoronok, V. R. Gutmane, T. M. Baryash, O. V. Soldatenko, T. V. Znovets, V. M. Mitsura, E. V. Voropaev, E. L. Gasich, E. N. Yagovdik-Telezhnaja, L. V. Sivachenko, L. A. Anisko, L. S. Zhmurovskaja, S. V. Krapivina, N. N. Yurovskij, I. V. Yurkevich, I. A. Karpov
Publikováno v:
Журнал инфектологии, Vol 10, Iss 3, Pp 77-83 (2018)
To evaluate the efficacy of therapy with sofosbuvir in combination with ledipasvir or daclatasvir, the results of treatment of 299 patients with chronic hepatitis C, including 128 non-responders to combined interferon plus ribavirin therapy, who have
Externí odkaz:
https://doaj.org/article/80835850f61049828397919f62dee729